Skip to Main Content

Paper Details

Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma.
Mol Cell Proteomics
140
2015
Cancer, Plasma, cancer, human, human plasma, patient, plasma
Author NameAffiliation
Susan E AbbatielloFrom the Broad Institute of MIT and Harvard
Susan E AbbatielloFrom the Broad Institute of MIT and Harvard
Birgit SchillingBuck Institute for Research on Aging
Birgit SchillingBuck Institute for Research on Aging
Deepak ManiFrom the Broad Institute of MIT and Harvard
Lisa J ZimmermanVanderbilt University School of Medicine, and the Jim Ayers Institute for Precancer Detection and Diagnosis, Vanderbilt-Ingram Cancer Center
Steven C HallUniversity of California san francisco
Brendan MacLeanUniversity of Washington School of Medicine
Matthew E AlbertolleUniversity of California san francisco
Simon AllenUniversity of California san francisco
Michael BurgessFrom the Broad Institute of MIT and Harvard
Michael P CusackBuck Institute for Research on Aging
Mousumi GoshMemorial Sloan-Kettering Cancer Center
Victoria HedrickPurdue University
Jason M HeldBuck Institute for Research on Aging
Halina D InerowiczPurdue University
Angela M JacksonUniversity of Victoria-Genome BC Proteomics Centre
Hasmik KeshishianFrom the Broad Institute of MIT and Harvard
Christopher R KinsingerNational Cancer Institute, National Institutes of Health
John S LyssandKimmel Center for Biology and Medicine at the Skirball Institute, New York University School of Medicine
Lee MakowskiArgonne National Laboratory (currently at Northeastern University
Mehdi MesriNational Cancer Institute, National Institutes of Health
Henry RodriguezNational Cancer Institute, National Institutes of Health
Henry RodriguezNational Cancer Institute, National Institutes of Health
Paul A RudnickNational Institute of Standards and Technology
Pawel SadowskiKimmel Center for Biology and Medicine at the Skirball Institute, New York University School of Medicine
Nell SedranskNational Institute of Statistical Sciences
Kent ShaddoxVanderbilt University School of Medicine, and the Jim Ayers Institute for Precancer Detection and Diagnosis, Vanderbilt-Ingram Cancer Center
Steven J SkatesMassachusetts General Hospital
Eric KuhnFrom the Broad Institute of MIT and Harvard
Derek SmithUniversity of Victoria-Genome BC Proteomics Centre
Jeffrey R WhiteakerFred Hutchinson Cancer Research Center
Corbin W WhitwellVanderbilt University School of Medicine, and the Jim Ayers Institute for Precancer Detection and Diagnosis, Vanderbilt-Ingram Cancer Center
Shucha ZhangFred Hutchinson Cancer Research Center
Christoph H BorchersUniversity of Victoria-Genome BC Proteomics Centre
Christoph H BorchersUniversity of Victoria-Genome BC Proteomics Centre
Susan J FisherUniversity of California san francisco
Susan J FisherUniversity of California san francisco
Bradford W GibsonBuck Institute for Research on Aging
Bradford W GibsonBuck Institute for Research on Aging
Daniel C LieblerVanderbilt University School of Medicine, and the Jim Ayers Institute for Precancer Detection and Diagnosis, Vanderbilt-Ingram Cancer Center
Michael J MacCossUniversity of Washington School of Medicine
Michael J MacCossUniversity of Washington School of Medicine
Thomas A NeubertKimmel Center for Biology and Medicine at the Skirball Institute, New York University School of Medicine
Thomas A NeubertKimmel Center for Biology and Medicine at the Skirball Institute, New York University School of Medicine
Amanda G PaulovichFred Hutchinson Cancer Research Center
Fred E RegnierPurdue University
Paul TempstMemorial Sloan-Kettering Cancer Center
Paul TempstMemorial Sloan-Kettering Cancer Center
Steven A CarrFrom the Broad Institute of MIT and Harvard
  • 1 - 50

Datasets